We are live on ! Find out more
PROF

Profound Medical

39 hedge funds and large institutions have $62.8M invested in Profound Medical in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,229% more call options, than puts

Call options by funds: $3.06M | Put options by funds: $230K

3.5% less ownership

Funds ownership: 45.26%41.76% (-3.5%)

11% less funds holding

Funds holding: 4439 (-5)

17% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 12

26% less capital invested

Capital invested by funds: $84.6M → $62.8M (-$21.9M)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
39
Holders Change
-5
Holders Change %
-11.36%
% of All Funds
0.66%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
4
Increased
10
Reduced
12
Closed
7
Calls
$3.06M
Puts
$230K
Net Calls
+$2.83M
Net Calls Change
-$665K

PROF Hedge Fund Activity: Q2 2022 in Review

39 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Profound Medical (PROF) for Q2 2022, worth a combined $62.8M — down 26% from $84.6M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of PROF and 4 opened new positions — a net loss of 3 holders — while 12 trimmed existing stakes and 10 added.

The largest buyer was Royal Bank of Canada, adding an estimated $516K. The largest seller was AWM Investment Company, cutting an estimated $2.08M.

  • 39 institutional investors held Profound Medical (PROF) as of Q2 2022, down from 44 in Q1 2022.
  • Funds reported $62.8M of Profound Medical stock for Q2 2022, down 26% quarter-over-quarter.
  • 4 funds opened new Profound Medical positions in Q2 2022 and 7 closed out, a net change of -3 holders.
  • The largest Profound Medical buyer in Q2 2022 was Royal Bank of Canada, an estimated $516K added.
  • The largest Profound Medical seller in Q2 2022 was AWM Investment Company, an estimated $2.08M sold.

Based on aggregated 13F filings for Q2 2022.